Poland· PL-100094914
Krople żołądkowe forte
A medicinal product containing preparat złożony, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990494118
- gtin05909990494125
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f70cd22e-8b4b-4ef9-b848-00bf393b532d GET /v1/drugs/f70cd22e-8b4b-4ef9-b848-00bf393b532d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Płyn doustny",
"source": "urpl",
"strength": "-",
"packaging": "05909990494118 ¦ OTC ¦ 15726\n1 butelka 39 ml\n05909990494125 ¦ OTC ¦ Skasowane ¦ 15727\n1 butelka 100 g",
"substance": "Amara tinctura (1:5) ekstrahent-etanol 70st. 25 g + Valerianae tinctura (1:5) ekstrahent-etanol 70st. 25 g + Hyperici tinctura (1:4,47) ekstrahent-etanol 70st. 25 g + Menthae piperitae tinctura (1:20) ekstrahent-etanol 90st. 25 g",
"common_name": "Preparat złożony",
"pl_product_id": "100094914",
"pozwolenie_nr": "04941",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about preparat złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.